Skip to main content

Peer Review reports

From: Safety and efficacy analysis of chemoradiotherapy/radiotherapy combined with nimotuzumab for treating unresectable oesophageal squamous cell carcinoma in elderly patients: a retrospective analysis

Original Submission
16 May 2022 Submitted Original manuscript
13 Jun 2022 Reviewed Reviewer Report - Madhup Rastogi
15 Sep 2022 Reviewed Reviewer Report
1 Oct 2022 Reviewed Reviewer Report - Hironaga Satake
21 Oct 2022 Author responded Author comments - Jun Liang
13 Nov 2022 Reviewed Reviewer Report - Hironaga Satake
21 Nov 2022 Author responded Author comments - Jun Liang
Resubmission - Version 2
21 Oct 2022 Submitted Manuscript version 2
22 Nov 2022 Author responded Author comments - Jun Liang
Resubmission - Version 3
22 Nov 2022 Submitted Manuscript version 3
28 Nov 2022 Reviewed Reviewer Report - Hironaga Satake
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
2 Dec 2022 Editorially accepted
17 Dec 2022 Article published 10.1186/s12876-022-02602-5

You can find further information about peer review here.

Back to article page